pipette
ESEspañol

Functional analysis of NANOS protein variants identified in men with infertility employing zebrafish embryos

S. Madiwale, A. Gupta, L. Schmidthuis, C. G. Krausz, V. Bonini, S. Kliesch, C. Friedrich, F. Tuettelmann, E. Raz

PreprintReal-world use

In the authors' words

Study question: Are vertebrate NANOS proteins associated with human fertility, and can a rapid in vivo assay in zebrafish be established to evaluate the biological activity of human NANOS variants? Summary answer: Combining a rapid in vivo assay we developed for Nanos protein activity and patient-derived genetic data, we identified NANOS variants that could contribute to male infertility. What is known already: Male infertility affects approximately 17% of the population, but linking specific gene variants to this condition remains challenging. NANOS proteins are essential regulators of germ cell development in different model organisms; however, a rapid and robust in vivo assay for evaluating their activity in the context of human male infertility is currently lacking. Study design, size, duration: Exome/genome data from 3,338 men included in the Male Reproductive Genomics (MERGE) cohort were examined in this study. Of these, 2038 men showed severely impaired spermatogenesis but were otherwise healthy. Ninety-Six men with intact spermatogenesis were included in the study as controls. Additionally, the study included a targeted analysis of NANOS variants in 44 patients from the IMIGC cohort. Participants/materials, setting, methods: The exome/genome data were screened for rare, stop-gain, frameshift, splice site, as well as missense variants in NANOS1, NANOS2, and NANOS3. Human amino acid substitutions were introduced at the corresponding positions in the zebrafish proteins. Ectopic co-expression of wild-type Dnd1 and Nanos3 in zebrafish embryos induces a germ cell-like fate in somatic cells, resulting in severe developmental defects and embryonic lethality. Based on this principle, we established a rapid in vivo assay in which wild-type Dnd1 was co-expressed with wild-type or variant Nanos2 and Nanos3 proteins in live zebrafish embryos, expecting early embryonic death if a variant protein is functional. This assay was used to evaluate the activity of NANOS2 and NANOS3 variants identified in men with infertility. Main results and the role of chance: In human exome/genome sequencing data, we identified one heterozygous missense variant in NANOS2 and two heterozygous missense variants in NANOS3. The function of the variants was examined in the zebrafish using the in vivo assay we developed. Co-expression of wild-type Dnd1 with selected Nanos2 or Nanos3 variants identified in infertile men resulted in defects in induction of the germ cell-like phenotype, demonstrating the power of the biological readout for evaluating the potential effects of patient-derived variants on NANOS protein activity. Together, our analysis enabled the evaluation of single nucleotide variants, whose impact on protein function is difficult to predict, and allowed us to distinguish variants with little or no effect on protein function from those that strongly reduce activity and may potentially contribute to infertility. Limitations, reasons for caution: The assay requires access to zebrafish embryos and basic imaging equipment. Although the functional conservation of NANOS proteins between zebrafish and humans is supported by previous studies, species-specific differences may influence protein activity. Therefore, the zebrafish assay should be considered one component of a broader framework for evaluating NANOS variants as contributing factor for infertility. Wider implications of the findings: Using NANOS2 and NANOS3 as examples, we demonstrate that integrating clinical genetic data with functional cell and developmental biology can help establish links between candidate disease genes and human fertility. This strategy may apply to other germline-specific genes whose ectopic expression produces measurable developmental phenotypes in zebrafish embryos.

Main resultLimitation the authors admit

Appeared: Sunday, October 25. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.20.26366003